the present invention relates to novel benzotriazoles of the formula i wherein het is an optionally substituted 5 - membered heterocycle containing one to two heteroatoms selected from nitrogen , sulfur and oxygen wherein at least one of said heteroatoms atoms must be nitrogen ; r 2 is selected from the group consisting of hydrogen , alkyl or other suitable substituents ; r 3 is selected from the group consisting of hydrogen , alkyl or other suitable substituents ; s is an integer from 0 - 5 ; to intermediates for their preparation , to pharmaceutical compositions containing them and to their medicinal use . the compounds of the present invention are potent inhibitors of map kinases , preferably p38 kinase . they are useful in the treatment of inflammation , osteoarthritis , rheumatoid arthritis , cancer , repurfusion or ischemia in stroke or heart attack , autoimmune diseases and other disorders .